Fwd: Marijuana Patent #[masked]

From: Kurtis W. H.
Sent on: Thursday, December 22, 2011 4:14 PM


Begin forwarded message:

From: "Rev. Tom Brown" <[address removed]>
Date: December 22,[masked]:46:38 PM CST
To: Arev Tom Brown <[address removed]>
Subject: Marijuana Patent #[masked]


Greetings,

Patent #[masked] is about to be granted to a company called Kanna Life Sciences.  Here is the article from the Federal Register.
 

Comments are invited, but the comment period ends MONDAY.  (You can email or fax them.) Please hurry if you have anything to say about the granting of the patent.  

Here is the information:

Betty B. Tong, Ph.D.

Senior Licensing and Patenting Manager

 
Office of Technology Transfer

National Institutes of Health

6011 Executive Boulevard, Suite 325

Rockville MD[masked]
 
fax (301)[masked]
[address removed]

This is a WORLDWIDE and EXCLUSIVE patent.  It covers "Cannabinoids as antioxidants and neuroprotectants." The disease that KannaLife is targeting is Hepatic Encephalopathy

Here's the wikipedia article on Hepatic Encephalopathy:
http://en.wikipedia.org/wiki/Hepatic_encephalopathy 

Here is Carl Olsen's letter.  He has a very good point.

Betty B. Tong, Ph.D.
Senior Licensing and Patenting Manager
Office of Technology Transfer
National Institutes of Health
6011 Executive Boulevard, Suite 325
Rockville MD[masked]

fax (301)[masked]
[address removed]


Re: Prospective Grant of Exclusive License: Development of Cannabinoid(s) and Cannabidiol(s) Based Therapeutics To Treat Hepatic Encephalopathy in Humans.
Federal Register /Vol. 76, No. 222 /Thursday, November 17, 2011 /Notices 71351


Dear Dr. Tong,

I'd like to oppose the transfer of any license to a pharmaceutical company to produce any product containing naturally extracted cannabinoids until marijuana is transferred to another schedule or removed from the Controlled Substances Act. Coca plants and opium poppies are in schedule II because they are the botanical sources for federally approved pharmaceutical products. Removing marijuana from schedule I would provide the same benefits for pharmaceutical manufacture of naturally occurring cannabinoids.

While I applaud any effort to use marijuana for medical purposes, it's federal scheduling should be amended to reflect that reality.

Thank you so much!

Carl Olsen

I will be writing them next.  I plan to echo Carl Olsen's point closely.

One Louve,
Nancy



People in this
Meetup are also in:

Sign up

Meetup members, Log in

By clicking "Sign up" or "Sign up using Facebook", you confirm that you accept our Terms of Service & Privacy Policy